ES2087463T3 - Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central. - Google Patents

Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central.

Info

Publication number
ES2087463T3
ES2087463T3 ES92310406T ES92310406T ES2087463T3 ES 2087463 T3 ES2087463 T3 ES 2087463T3 ES 92310406 T ES92310406 T ES 92310406T ES 92310406 T ES92310406 T ES 92310406T ES 2087463 T3 ES2087463 T3 ES 2087463T3
Authority
ES
Spain
Prior art keywords
treatment
nervous system
central nervous
rent
thiofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92310406T
Other languages
English (en)
Spanish (es)
Inventor
John Fairhurst
David Edward Tupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919124439A external-priority patent/GB9124439D0/en
Priority claimed from GB929218112A external-priority patent/GB9218112D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of ES2087463T3 publication Critical patent/ES2087463T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
ES92310406T 1991-11-18 1992-11-13 Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central. Expired - Lifetime ES2087463T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919124439A GB9124439D0 (en) 1991-11-18 1991-11-18 Pharmaceutical compounds
GB929218112A GB9218112D0 (en) 1992-08-26 1992-08-26 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ES2087463T3 true ES2087463T3 (es) 1996-07-16

Family

ID=26299883

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92310406T Expired - Lifetime ES2087463T3 (es) 1991-11-18 1992-11-13 Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central.

Country Status (9)

Country Link
US (1) US5338735A (de)
EP (1) EP0543584B1 (de)
JP (1) JPH05194485A (de)
AT (1) ATE138374T1 (de)
CA (1) CA2082839A1 (de)
DE (1) DE69210959T2 (de)
DK (1) DK0543584T3 (de)
ES (1) ES2087463T3 (de)
GR (1) GR3020488T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
FR2793793B1 (fr) * 1999-05-19 2004-02-27 Adir Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
TW201212918A (en) * 2010-08-23 2012-04-01 Lundbeck & Co As H Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL133069C (de) * 1966-07-29
MC807A1 (fr) * 1968-07-29 1970-07-30 Soc Et Scient Et Ind De L Ile Procédé de préparation de 3-alcoxy-thianaphtene-carboxamide substituées ou non
US3838169A (en) * 1968-07-29 1974-09-24 Ile De France 3-alkoxy-thianaphthene-2-carboxamides
IL74694A0 (en) * 1984-04-02 1985-06-30 Merck & Co Inc N-alkenyl-3-hydroxybenzo(b)thiophene-2-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
US4782080A (en) * 1985-09-16 1988-11-01 Merck & Co., Inc. N-alkenyl-2-hydroxybenzo(b)thiophene-3-carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors
US4800211A (en) * 1986-08-18 1989-01-24 Merck & Co., Inc. 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
JPH05194485A (ja) 1993-08-03
EP0543584A1 (de) 1993-05-26
DE69210959D1 (de) 1996-06-27
DK0543584T3 (da) 1996-07-01
US5338735A (en) 1994-08-16
GR3020488T3 (en) 1996-10-31
EP0543584B1 (de) 1996-05-22
ATE138374T1 (de) 1996-06-15
DE69210959T2 (de) 1996-09-26
CA2082839A1 (en) 1993-05-19

Similar Documents

Publication Publication Date Title
ES2113368T3 (es) Antagonistas de serotonina.
ES2065691T3 (es) Derivados de quinuclidina.
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2160596T3 (es) Derivados de quinuclidina como antagonistas de la sustancia p.
ES2138977T3 (es) Agonistas muscarinicos.
CO4410331A1 (es) Derivados triciclicos del pirazol
NO923975D0 (no) 2-aminometyl-kroman
ES2056928T3 (es) Compuestos heterociclicos.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2113081T3 (es) 1,4-benzotiazepinas utiles como agentes neurologicos.
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES2120404T3 (es) Heteroarilamino- y heteroariloxipiridinaminas y compuestos afines, un procedimiento para su preparacion y su uso como medicamentos.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
ES2132580T3 (es) Derivados de aroil-piperidina.
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
ES2038707T3 (es) Procedimiento para la obtencion de enantiomeros (+) y (-) de derivados de la 3,4-dihidro-2h-(1)-benzopiran-3-amina.
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
CO5160242A1 (es) UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ES2122253T3 (es) Derivados (arilalcoxibencil)aminopropanamidicos sustituidos, su preparacion y su utilizacion como agentes antiepilepticos, neuroprotectores y antidepresivos.
SE8505887L (sv) Indoler
ES2087463T3 (es) Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0543584

Country of ref document: ES